Overview:
ProductName | Troglitazone |
Description | PPARgammaagoNIST |
Purity | >98% |
CASNo. | 97322-87-7 |
MolecularFormula | C24H27NO5S |
MolecularWeight | 441.54 |
Properties
StorageTemperature | -20ºC |
ShippingTemperature | ShippedAmbient |
ProductType | Agonist |
Solubility | Solubleto100mMinDMSOandto10mMinethanol |
Source | Synthetic |
Appearance | Whitesolid |
SMILES | CC1=C(C2=C(CCC(O2)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=C1O)C)C |
InChI | InChI=1S/C24H27NO5S/c1-13-14(2)21-18(15(3)20(13)26)9-10-24(4,30-21)12-29-17-7-5-16(6-8-17)11-19-22(27)25-23(28)31-19/h5-8,19,26H,9-12H2,1-4H3,(H, |
InChIKey | GXPHKUHSUJUWKP-UHFFFAOYSA-N |
SafetyPhrases | Classification:Harmful.Maybeharmfulifinhaled,swallowedorabsorbedthroughskin.SafetyPhrases:S22-DonotbreathedustS24/25-AvoidcontactwithskinandeyesS36/37/39-Wearsuitableprotectiveclothing,glovesandeye/faceprotectionRiskPhrases:R20/21/22-Harmfulbyinhalation,incontactwithskinandifswallowedR40-Limitedevidenceofacarcinogeniceffect |
CiteThisProduct | Troglitazone(StressMarqBiosciencesInc.,VictoriaBCCANADA,Catalog#SIH-260) |
BIOLOGicalDescription
AlternativeNames | 5-{4-[(6-Hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl)methoxy]benzyl}-1,3-thiazolidine-2,4-dione,Rezulin |
ResearchAreas | Cancer,Apoptosis |
PubChemID | 5591 |
ScientificBackground | Troglitazone,amemberofthethaizolidinediones,isananti-diabeticandanti-inflammatorydrug.Itworksbyactivatingperoxisomeproliferator-activatedreceptors(PPARs)(1).ItisaligandtobothPPARalphaandgamma.Italsocontainsanalpha-tocopheroylmoiety,potentiallygivingitvitaminElikeactivity(whichhelpsininflammation)(2). |
References | 1.LambeK.G.andTugwoodJ.D.(1996)EurJBiochem.239(1):1-7. 2.AljadaA.,etal.(2001)JClinEndocrinolMetab.86(7):3250-3256. |
ProductImages
ChemicalstructureofTroglitazone(SIH-260),aPPARgammaagonist.CAS#:97322-87-7.MolecularFormula:C24H27NO5S.MolecularWeight:441.54g/mol.
ProductCitations(0)
Currentlytherearenocitationsforthisproduct.